These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26569085)

  • 41. Treatment for pulmonary arterial hypertension-associated right ventricular dysfunction.
    Gomez-Arroyo J; Sandoval J; Simon MA; Dominguez-Cano E; Voelkel NF; Bogaard HJ
    Ann Am Thorac Soc; 2014 Sep; 11(7):1101-15. PubMed ID: 25079379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.
    Melnick L; Barst RJ; Rowan CA; Kerstein D; Rosenzweig EB
    Am J Cardiol; 2010 May; 105(10):1485-9. PubMed ID: 20451700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Six-minute walking distance and decrease in oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertension.
    Douwes JM; Hegeman AK; van der Krieke MB; Roofthooft MT; Hillege HL; Berger RM
    Int J Cardiol; 2016 Jan; 202():34-9. PubMed ID: 26386916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry.
    Farber HW; Miller DP; Meltzer LA; McGoon MD
    J Heart Lung Transplant; 2013 Nov; 32(11):1114-22. PubMed ID: 24035189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current and advancing treatments for pulmonary arterial hypertension in childhood.
    Zijlstra WM; Ploegstra MJ; Berger RM
    Expert Rev Respir Med; 2014 Oct; 8(5):615-28. PubMed ID: 25047735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary hypertension and pregnancy: an overview.
    Gei A; Montúfar-Rueda C
    Clin Obstet Gynecol; 2014 Dec; 57(4):806-26. PubMed ID: 25314091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Mielniczuk LM; Swiston JR; Mehta S
    Can J Cardiol; 2014 Oct; 30(10):1233-40. PubMed ID: 25154043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetics of pulmonary hypertension.
    Best DH; Austin ED; Chung WK; Elliott CG
    Curr Opin Cardiol; 2014 Nov; 29(6):520-7. PubMed ID: 25159282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recommended guideline for the use of medical therapy in pulmonary hypertension].
    Tanabe N
    Nihon Rinsho; 2008 Nov; 66(11):2133-8. PubMed ID: 19051732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.
    Haarman MG; Douwes JM; Ploegstra MJ; Roofthooft MTR; Vissia-Kazemier TR; Hillege HL; Berger RMF
    Am J Respir Crit Care Med; 2019 Nov; 200(10):1312-1315. PubMed ID: 31298925
    [No Abstract]   [Full Text] [Related]  

  • 53. Of Registries and Disease Classification: Unmasking the Challenges of Pediatric Pulmonary Hypertension.
    Abman SH; Mullen MP
    Am J Respir Crit Care Med; 2022 Sep; 206(6):664-665. PubMed ID: 35737949
    [No Abstract]   [Full Text] [Related]  

  • 54. Towards improving the care of children with pulmonary hypertension: The rationale for developing a Pediatric Pulmonary Hypertension Network.
    Abman SH; Raj U
    Prog Pediatr Cardiol; 2009 Dec; 27(1-2):3-6. PubMed ID: 24917695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isoprostane as a promising prognostic biomarker in pulmonary arterial hypertension: preanalytical and analytical viewpoints.
    Monneret D; Cracowski JL; Bonnefont-Rousselot D
    Int J Cardiol; 2014 Dec; 177(2):527-8. PubMed ID: 25183532
    [No Abstract]   [Full Text] [Related]  

  • 56. Thorax Innovation (TORINO).
    Humbert M
    Presse Med; 2013 Sep; 42(9 Pt 2):e301-2. PubMed ID: 23972546
    [No Abstract]   [Full Text] [Related]  

  • 57. Diagnosis and Management of Pulmonary Hypertension in the Modern Era: Insights from the 6th World Symposium.
    Thomas CA; Anderson RJ; Condon DF; de Jesus Perez VA
    Pulm Ther; 2020 Jun; 6(1):9-22. PubMed ID: 32048239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathological findings in nine children with primary pulmonary hypertension.
    BERTHRONG M; COCHRAN TH
    Bull Johns Hopkins Hosp; 1955 Aug; 97(2):69-111. PubMed ID: 13250284
    [No Abstract]   [Full Text] [Related]  

  • 59. Overview of current therapeutic approaches for pulmonary hypertension.
    Stamm JA; Risbano MG; Mathier MA
    Pulm Circ; 2011; 1(2):138-59. PubMed ID: 22034603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Building a dedicated pediatric pulmonary hypertension program: A consensus statement from the pediatric pulmonary hypertension network.
    Handler SS; Varghese NP; Rosenzweig EB; Yung D; Krishnan U; Whalen E; Bates A; Avitabile CM; Jackson EO; Hirsch R; Fineman J; Abman SH;
    Pulm Circ; 2022 Jan; 12(1):e12031. PubMed ID: 35506071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.